IBD and transplant prognosis in pediatric PSC

What is known

• A pediatric PSC cohort with 93% IBD showed good prognosis in the first decade, with an unfavorable outcome tied to a high SCOPE (severity) index at diagnosis rather than IBD status. ¹
• An increased need for liver transplantation was reported in PSC-AIH overlap versus PSC alone, though based on few events and possibly confounded by higher fibrosis stage. ¹
• In a long-term pediatric PSC study, AIH overlap did not affect survival; shorter transplant-free survival was associated with lower platelet count, splenomegaly, and older age. ²

What is unknown / caveats

• Retrieved studies on IBD and PSC transplant outcomes are largely adult cohorts or focus on IBD course after transplant, not pre-transplant prognosis in children
• No retrieved pediatric analysis directly compares transplant-free survival in PSC with versus without IBD
• None of the retrieved pediatric excerpts isolates IBD presence/absence as a predictor of transplant-free survival, so its independent prognostic effect in children cannot be determined here.

References

1. Jerregård Skarby A, Casswall T, Bergquist A, Lindström L. Good long-term outcomes of primary sclerosing cholangitis in childhood. JHEP Rep. 2024. PMID: 39139456.

2. Feldstein AE, Perrault J, El-Youssif M, Lindor KD, Freese DK, Angulo P. Primary sclerosing cholangitis in children: a long-term follow-up study. Hepatology. 2003. PMID: 12830004.

For educational use only, not a substitute for clinical judgement or medical advice. Consult qualified clinicians for diagnosis and treatment decisions. This tool may contain errors; use the flag button below to report inaccurate or harmful content.

Draft, generated by the IBDology RAG and not yet clinician-reviewed. Answers are grounded in the retrieved literature listed above; a high faithfulness score means the answer matches its sources, not that the sources are correct.